key: cord-0944773-m7rtyxxu
authors: Valentim, Flávia de Oliveira; Tsutsui, Giuliane Minami; Miot, Hélio Amante
title: Recrudescence of livedoid vasculopathy induced by COVID‐19
date: 2021-02-02
journal: Int J Dermatol
DOI: 10.1111/ijd.15423
sha: 75a2eae89405db087190ce6dad0e54895ab9322a
doc_id: 944773
cord_uid: m7rtyxxu

nan

and painful ulcers that often evolve into characteristic atrophic scars. The management of LV is difficult, as it evolves through a chronic and recurrent course. Relapses are associated with hot summer days, prolonged orthostatic posture, and risk factors for thrombosis (e.g., weight gain, contraceptive pills, and smoking). 1 We report on a 34-year-old female patient with histologically confirmed LV, with onset at 26 years old; no other comorbidities or coagulative disorders were identified. While the LV was refractory to anticoagulation (warfarin and rivaroxaban), the patient had been under clinical control with acetylsalicylic acid 300 mg/day, pentoxifylline 800 mg/day, cyclosporine 200 mg/day, and compression socks since 2018.

In the spring of 2020, the patient presented with an infection manifested by fever, sore throat, tinnitus, and cough, with 

Livedoid vasculopathy: an intringuing cutaneous disease

Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients

Cutaneous manifestations of SARS-CoV-2 infection: a clinical update

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Unraveling the mystery of Covid-19 cytokine storm: from skin to organ systems

Unpuzzling COVID-19 prothrombotic state: are preexisting thrombophilic risk profiles responsible for heterogenous thrombotic events?

Coagulopathy and antiphospholipid antibodies in patients with Covid-19

From dermatological conditions to COVID-19: reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy

Livedoid and purpuric skin eruptions associated with coagulopathy in severe COVID-19

COVID-19: an overview for dermatologists

COVID-19 cutaneous manifestations: simplifying the confusion

Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients